99 related articles for article (PubMed ID: 32199763)
21. Phase 2 study of intensified chemotherapy and allogeneic hematopoietic stem cell transplantation for older patients with acute lymphoblastic leukemia.
Fathi AT; DeAngelo DJ; Stevenson KE; Kolitz JE; Asch JD; Amrein PC; Attar EC; Steensma DP; Wadleigh M; Foster J; Connolly C; Galinsky I; Devoe CE; Stone RM; Neuberg DS; Ballen KK
Cancer; 2016 Aug; 122(15):2379-88. PubMed ID: 27171984
[TBL] [Abstract][Full Text] [Related]
22. Updated risk-oriented strategy for acute lymphoblastic leukemia in adult patients 18-65 years: NILG ALL 10/07.
Bassan R; Pavoni C; Intermesoli T; Spinelli O; Tosi M; Audisio E; Marmont F; Cattaneo C; Borlenghi E; Cortelazzo S; Cavattoni I; Fumagalli M; Mattei D; Romani C; Cortelezzi A; Fracchiolla N; Ciceri F; Bernardi M; Scattolin AM; Depaoli L; Masciulli A; Oldani E; Rambaldi A
Blood Cancer J; 2020 Nov; 10(11):119. PubMed ID: 33188164
[TBL] [Abstract][Full Text] [Related]
23. Outcomes and prognostic factors of adults with acute lymphoblastic leukemia who relapse after allogeneic hematopoietic cell transplantation. An analysis on behalf of the Acute Leukemia Working Party of EBMT.
Spyridonidis A; Labopin M; Schmid C; Volin L; Yakoub-Agha I; Stadler M; Milpied N; Socie G; Browne P; Lenhoff S; Sanz MA; Aljurf M; Mohty M; Rocha V;
Leukemia; 2012 Jun; 26(6):1211-7. PubMed ID: 22290066
[TBL] [Abstract][Full Text] [Related]
24. Factors Determining the Outcome of Hematopoietic Stem Cell Transplantation in Patients With Acute Lymphoblastic Leukemia at King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Al-Sweedan S; Al-Seraihy A; Al-Ahmari A; Al-Jefri A; Mohammed V; Jafri R; Siddiqui K; Ayas M
J Pediatr Hematol Oncol; 2017 Jan; 39(1):33-37. PubMed ID: 27906795
[TBL] [Abstract][Full Text] [Related]
25. Monosomal karyotype is associated with poor outcomes in patients with Philadelphia chromosome-negative acute lymphoblastic leukemia receiving chemotherapy but not allogeneic hematopoietic stem cell transplantation.
Li Z; Lai Y; Zhang X; Xu L; Liu K; Wang Y; Yan C; Jiang H; Huang X; Jiang Q
Ann Hematol; 2020 Aug; 99(8):1833-1843. PubMed ID: 32577842
[TBL] [Abstract][Full Text] [Related]
26. Nationwide survey of therapy-related leukemia in childhood in Japan.
Imamura T; Taga T; Takagi M; Kawasaki H; Koh K; Taki T; Adachi S; Manabe A; Ishida Y; ;
Int J Hematol; 2018 Jul; 108(1):91-97. PubMed ID: 29574603
[TBL] [Abstract][Full Text] [Related]
27. Outcome following second allogeneic hematopoietic cell transplantation: A single-center experience.
Aljasem HA; Messner HA; Lipton JH; Kim DDH; Viswabandya A; Thyagu S; Deotare U; Michelis FV
Eur J Haematol; 2018 Mar; 100(3):308-314. PubMed ID: 29240253
[TBL] [Abstract][Full Text] [Related]
28. [Prognostic analysis of allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in complete remission in the era of tyrosine kinase inhibitors].
Cao XY; Ma W; Zhang W; Liu DY; Zhao YL; Lu Y; Zhang JP; Zhou JR; Xiong M; Wei ZJ; Sun RJ
Zhonghua Xue Ye Xue Za Zhi; 2020 Jul; 41(7):564-569. PubMed ID: 32810963
[No Abstract] [Full Text] [Related]
29. Allogeneic hematopoietic stem cell transplantation for adult patients with mixed phenotype acute leukemia: results of a matched-pair analysis.
Shimizu H; Saitoh T; Machida S; Kako S; Doki N; Mori T; Sakura T; Kanda Y; Kanamori H; Miyawaki S; Okamoto S;
Eur J Haematol; 2015 Nov; 95(5):455-60. PubMed ID: 25605541
[TBL] [Abstract][Full Text] [Related]
30. Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia.
Brissot E; Labopin M; Beckers MM; Socié G; Rambaldi A; Volin L; Finke J; Lenhoff S; Kröger N; Ossenkoppele GJ; Craddock CF; Yakoub-Agha I; Gürman G; Russell NH; Aljurf M; Potter MN; Nagler A; Ottmann O; Cornelissen JJ; Esteve J; Mohty M
Haematologica; 2015 Mar; 100(3):392-9. PubMed ID: 25527562
[TBL] [Abstract][Full Text] [Related]
31. [Imatinib in combination with allogeneic hematopoietic stem cell transplantation improved the outcome of adult Philadelphia chromosome-positive acute lymphoblastic leukemia].
Cheng Z; Zhao L; Chen G; Wu D; Qiu H; Tang X; Fu C; Jin Z; Chen F; Xue S; Sun A
Zhonghua Xue Ye Xue Za Zhi; 2014 Feb; 35(2):114-9. PubMed ID: 24606651
[TBL] [Abstract][Full Text] [Related]
32. Phase II study of intensive post-remission chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia and lymphoblastic lymphoma: Japan Clinical Oncology Group Study, JCOG9402.
Azuma T; Tobinai K; Takeyama K; Shibata T; Hidaka M; Kurosawa M; Kasai M; Chou T; Fukushima N; Mukai K; Tsukasaki K; Shimoyama M;
Jpn J Clin Oncol; 2012 May; 42(5):394-404. PubMed ID: 22422899
[TBL] [Abstract][Full Text] [Related]
33. Prognostic factors and outcomes of unrelated bone marrow transplantation for Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL) pre-treated with tyrosine kinase inhibitors.
Yoshimura T; Nakane T; Hirose A; Koh H; Nakamae M; Aimoto M; Nishimoto M; Hayashi Y; Terada Y; Nakamae H; Hino M
Osaka City Med J; 2013 Jun; 59(1):9-21. PubMed ID: 23909077
[TBL] [Abstract][Full Text] [Related]
34. Retrospective Study of Allogeneic Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome-Positive Leukemia: 25 Years' Experience at Gustave Roussy Cancer Campus.
Chamseddine AN; Willekens C; De Botton S; Bourhis JH
Clin Lymphoma Myeloma Leuk; 2015 Jun; 15 Suppl():S129-40. PubMed ID: 26297265
[TBL] [Abstract][Full Text] [Related]
35. Clofarabine Plus Busulfan is an Effective Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: Long-Term Study Results.
Kebriaei P; Bassett R; Lyons G; Valdez B; Ledesma C; Rondon G; Oran B; Ciurea S; Alousi A; Popat U; Patel K; Ahmed S; Olson A; Bashir Q; Shah N; Jones R; Marin D; Rezvani K; Nieto Y; Khouri I; Qazilbash M; Hosing C; Shpall E; Champlin RE; Andersson BS
Biol Blood Marrow Transplant; 2017 Feb; 23(2):285-292. PubMed ID: 27816651
[TBL] [Abstract][Full Text] [Related]
36. T315I mutation exerts a dismal prognosis on adult BCR-ABL1-positive acute lymphoblastic leukemia, and salvage therapy with ponatinib or CAR-T cell and bridging to allogeneic hematopoietic stem cell transplantation can improve clinical outcomes.
Ting S; Mixue X; Lixia Z; Xueying L; Wanzhuo X; Xiujin Y
Ann Hematol; 2020 Apr; 99(4):829-834. PubMed ID: 32107574
[TBL] [Abstract][Full Text] [Related]
37. Implications and Management of Central Nervous System Involvement before Allogeneic Hematopoietic Cell Transplantation in Acute Lymphoblastic Leukemia.
Aldoss I; Al Malki MM; Stiller T; Cao T; Sanchez JF; Palmer J; Forman SJ; Pullarkat V
Biol Blood Marrow Transplant; 2016 Mar; 22(3):575-8. PubMed ID: 26493564
[TBL] [Abstract][Full Text] [Related]
38. Cytogenetic risk determines outcomes after allogeneic transplantation in older patients with acute myeloid leukemia in their second complete remission: A Center for International Blood and Marrow Transplant Research cohort analysis.
Michelis FV; Gupta V; Zhang MJ; Wang HL; Aljurf M; Bacher U; Beitinjaneh A; Chen YB; DeFilipp Z; Gale RP; Kebriaei P; Kharfan-Dabaja M; Lazarus HM; Nishihori T; Olsson RF; Oran B; Rashidi A; Rizzieri DA; Tallman MS; de Lima M; Khoury HJ; Sandmaier BM; Weisdorf D; Saber W;
Cancer; 2017 Jun; 123(11):2035-2042. PubMed ID: 28117898
[TBL] [Abstract][Full Text] [Related]
39. Retrospective analysis of adult patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic cell transplantation: A multicenter experience of daily practice.
Tekgündüz E; Kaynar L; Göker H; Kaya AH; Turak EE; Eliaçık E; Kayıkçı Ö; Çetin M; Büyükaşık Y; Eser B; Altuntaş F
Transfus Apher Sci; 2016 Feb; 54(1):41-7. PubMed ID: 26810140
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and prognostic factors of imatinib plus CALLG2008 protocol in adult patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.
Lou Y; Ma Y; Li C; Suo S; Tong H; Qian W; Mai W; Meng H; Yu W; Mao L; Wei J; Xu W; Jin J
Front Med; 2017 Jun; 11(2):229-238. PubMed ID: 28349299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
